Back to News
Market Impact: 0.15
AC Immune SA Reports Third Quarter 2026 Financial Results and CHF 73.9 million Cash Balance
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
AC Immune reported CHF 73.9 million in total cash resources as of September 30, 2026, including CHF 18.7 million in cash and cash equivalents and CHF 55.2 million in short-term financial assets. The provided article text contains no further operating updates or outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Snap shares fall over 10% on third-quarter earnings miss
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- Drone Attacks Spawn New Insurance Market in Baltics, Poland
- REA Group shares rally on strong Q1 revenue